2026-05-14T08:40:16-05:00 2025-06-30 991856619 GRANT THORNTON ADVISORS LLC 5955 TG LEE BOULEVARD SUITE 200 ORLANDO FL 32801 990 2024-07-01 593238640 H LEE MOFFITT CANCER CENTER & RESEARCH INST LIFETIME CANCER SCREENING CTR INC HLEE 8137454673 12902 MAGNOLIA DRIVE TAMPA FL 33612 JOANNA WEISS EVP/CFO 8137451188 2026-05-13 1 0 MICHELE N MELCHIOR P00488037 4074815100 2024 2025-03-06 01:10:19Z MOFFITT MEDICAL GROUP KAREN LU 12902 MAGNOLIA DRIVE TAMPA FL 33612 173244422 0 X HTTPS://MOFFITT.ORG/ABOUT-MOFFITT/MEDICAL/ X 1994 FL TO PROMOTE AND SUPPORT H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. AND ITS SUBS. 11 11 1415 29 12051050 634077 1767633 2206547 143829512 171020052 0 0 63295 17823 145660440 173244422 0 0 0 0 309623343 354518472 0 0 0 31380666 30647825 341004009 385166297 -195343569 -211921875 16567329 19656405 20499180 23679123 -3931851 -4022718 X TO PROMOTE AND SUPPORT H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC (INSTITUTE), H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL (HOSPITAL), AND H. LEE MOFFITT CANCER FOUNDATION BY EMPLOYING PHYSICIANS WHO STAFF THE HOSPITAL, BY MANAGING THEIR PRACTICE AND BY EMPLOYING THE CLINICAL SCIENTISTS WHO PROVIDE CLINICAL RESEARCH SERVICES. 0 0 346269647 158974002 H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING CENTER, INC. ("LCS") EMPLOYS THE PHYSICIANS (KNOWN AS THE MOFFITT MEDICAL GROUP) THAT STAFF THE HOSPITAL AND PROVIDE CLINICAL RESEARCH SERVICES TO THE CANCER CENTER HEALTH CARE SYSTEM. THE PROVISION OF PRACTICE MANAGEMENT SERVICES TO ITS EMPLOYED PHYSICIANS AND CLINICAL SCIENTISTS ENHANCES THE EFFICIENCY OF HEALTHCARE AND RESEARCH SERVICES PROVIDED BY THESE EMPLOYEES. THIS BENEFITS ALL ENTITIES IN THE CANCER CENTER HEALTH CARE SYSTEM AND PROMOTES AND SUPPORTS THE RESEARCH AND ACADEMIC MISSIONS OF THE CANCER CENTER HEALTH CARE SYSTEM. 346269647 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 1 0 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 24 0 1 1415 1 1 1 0 0 0 0 0 0 0 0 0 X 11 11 1 0 0 0 1 1 1 1 0 0 0 1 1 1 1 1 1 0 0 0 X JOANNA WEISS 8137451188 12902 MAGNOLIA DR TAMPA FL 33612 X MICHAEL A VOGELBAUM PRG LDR NEURO ONCOLOGY 50.00 0.00 X 1199083 0 81546 JULIO M POW-SANG MD DEPT CHAIR GU 50.00 0.00 X 1037540 0 221041 G DOUGLAS LETSON FRM PRES, EVP-PIC TO 6/2024 19.00 36.00 X 597591 426431 162524 RICARDO J GONZALEZ DEPT CHAIR SARCOMA 50.00 0.00 X 1024757 0 146170 LARY ROBINSON SR MBR THORCARDIO 50.00 0.00 X 1021735 0 133786 ERIC TOLOZA VICE CHAIR THORACIC 50.00 0.00 X 1035085 0 95663 L DAVID DE LA PARTE FRM EVP-GEN CO; ASST SEC TO 6/2024 5.00 53.00 X 0 800163 242023 ROBERT A GATENBY DEPT CHAIR DIAGNOSTIC IMAGING 55.00 0.00 X 897178 0 151113 JOANNA WEISS EVP CFO & ASST TREASURER 5.00 55.00 X 0 833387 139001 HUGO FERNANDEZ MD DIR, DEPT CHAIR MAL HEM MHS 56.00 0.00 X 870600 0 120269 PETER JOHSTONE DEPT CHAIR RADIATION ONCOLOGY 55.00 0.00 X 848315 0 116517 KOSJ YAMOAH DEPT CHAIR RADIATION ONCOLOGY 55.00 0.00 X 886273 0 80702 JOHN A ARRINGTON VICE CHAIR DIAGNOSTIC IMAGING 55.00 0.00 X 773342 0 160713 DONALD L KLIPPENSTEIN VICE CHAIR DIAGNOSTIC IMAGING 55.00 0.00 X 733413 0 130764 BELA KIS VICE CHAIR DIA IMAGING AS OF 12/2024 55.00 0.00 X 702748 0 96459 DAVID N THRUSH FRM DEPT CHAIR ANESTH TO 6/2023 50.00 0.00 X 593847 0 105798 SEPHALIE PATEL DEPT CHAIR ANESTHESIOLOGY 55.00 0.00 X 639002 0 58109 NIKHIL KHUSHALANI DIR, ACD CLIN RES PART 56.00 0.00 X 586026 0 89010 SUSAN VADAPARAMPIL DIRECTOR NV 1.00 50.00 X 0 556294 103021 CHARLES FLETCHER EVP-GEN COUN & ASST SEC AS OF 7/2024 5.00 55.00 X 0 544342 117472 KAREN LU PRES, EVP-PIC 12.00 43.00 X 0 617813 16406 KAREN WARTENBERG VP MOFFITT MEDICAL GROUP 30.00 25.00 X 0 497383 118439 JONATHAN COHEN VICE CHAIR ANESTHESIOLOGY 55.00 0.00 X 535751 0 89638 EVAN ZASLOW VP PAYER STRATEGIES 19.00 36.00 X 0 449858 104950 NASRIN ALDAWOODI VICE CHAIR ANESTHESIOLOGY TO 11/2024 55.00 0.00 X 477416 0 60142 MELISSA SMITH VP FINANCE AS OF 8/2024 12.00 43.00 X 108421 135274 52706 YVETTE M LYONS TREMONTI FRM EVP-CFAO & ASST TREAS TO 5/2024 0.00 0.00 X 0 530115 65937 HENRY REYES FRM VP-PARTNER DEV TO 4/2024 0.00 0.00 X 0 105667 25185 VICTOR YOUNG DIRECTOR, CHAIR AS OF 10/2024 2.00 0.00 X X 0 0 0 FRANK CAPITANO DIRECTOR, IMMED PAST CHAIR 1.00 0.00 X X 0 0 0 THE HON H LEE MOFFITT ESQ DIRECTOR, SECRETARY/TREAS 2.00 2.00 X X 0 0 0 MICHAEL BICE DIRECTOR AS OF 3/2025 1.00 2.00 X 0 0 0 JOEDRECKA BROWN SPEIGHTS MD DIRECTOR 1.00 0.00 X 0 0 0 KATHERINE CHUNG-BRIDGES DIRECTOR 1.00 0.00 X 0 0 0 REGINALD GOINS DIRECTOR 1.00 1.00 X 0 0 0 ALLAN S MARTIN DIRECTOR AS OF 10/2024 1.00 0.00 X 0 0 0 MICHAEL O'MALLEY DIRECTOR 1.00 0.00 X 0 0 0 ROBERT J PEREZ DIRECTOR 1.00 0.00 X 0 0 0 THE HON MARK A PIZZO ESQ DIRECTOR 1.00 2.00 X 0 0 0 MARK WATSON DIRECTOR TO 3/2025 1.00 1.00 X 0 0 0 14568123 5496727 3085104 904 1 1 0 EMATB LLC 2502 W SAINT ISABEL ST TAMPA FL 336076318 OUTSOURCED CLINICAL SERVICES 3356251 MEDICAL DOCTOR ASSOCIATES LLC 145 TECHNOLOGY PKWY NORCROSS GA 300922913 TEMPORARY LABOR 2920007 LOCUMTENENS 2655 NORTHWINDS PKWY ALPHARETTA GA 300092280 TEMPORARY LABOR 1198315 UMSA INC 12901 BRUCE B DOWNS BLVD TAMPA FL 33612 OUTSOURCED CLINICAL SERVICES 649871 BUCHANAN INGERSOLL 501 E KENNEDY BLVD STE 2400 TAMPA FL 336025236 LEGAL SERVICES 525772 8 49728 26526 2130293 2206547 NET PATIENT SERVICE REVENUE 541900 157753136 157753136 MANAGEMENT SERVICES 541610 12097450 46400 12051050 QUALITY IMPROVEMENT PROGRAM 541900 632520 632520 PHYSICIAN AFFILIATE FEES 541900 468394 468394 CHART/SLIDE REVIEW REIMBURSEMENT 541900 62651 62651 5901 5901 171020052 INTEREST FROM INS CO 524298 12823 12823 STIPEND 900099 5000 5000 17823 173244422 158974002 12051050 12823 X 8416215 8226443 189772 1381961 1350800 31161 295059010 272296414 22762596 17205863 16040980 1164883 16470393 15188338 1282055 15985030 14562687 1422343 577691 577691 50365 50365 5576381 4427507 1148874 2580356 6966 2573390 1298509 116416 1182093 7467458 7467458 1777746 1777746 911521 494217 417304 23800 23800 109318 109318 1999949 1999949 950613 950613 ALLOC OF I/C EXPENSES 0 7997000 -7997000 BAD DEBT EXPENSES 2852530 2852530 0 PROFESSIONAL DVLPMNT 2396651 2220622 176029 DUES & SUBSCRIPTIONS 621493 315229 306264 1453444 173498 1279946 385166297 346269647 38896650 0 16285530 19345707 281573 253678 165745 108725 226 57020 16567329 19656405 20499180 23679123 20499180 23679123 X -3931851 -4022718 -3931851 -4022718 16567329 19656405 X -211921875 211831009 X 0 1 X 1 0 X 1704551 1277920 1966479 1767633 2206547 8923130 102282293 115157808 123797991 133836456 158974002 634048550 103986844 116435728 125764470 135604089 161180549 642971680 0 0 0 642971680 457935 549563 347270 635077 1989845 185964 21300 10925 63295 12823 294307 104630743 117006591 125775395 136014654 161828449 645255832 0.99650 0.99540 0.00000 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: REIMBURSEMENT - 2023 AMOUNT: $ 50,000. INTEREST FROM INS CO - 2020 AMOUNT: $ 8,631. 2021 AMOUNT: $ 21,300. 2022 AMOUNT: $ 10,925. 2023 AMOUNT: $ 13,295. 2024 AMOUNT: $ 12,823. MISC - 2020 AMOUNT: $ 238. TAX REFUND - 2020 AMOUNT: $ 177,095. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 165745 108725 57020 57020 X PART X, LINE 2: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING CENTER, INC. DID NOT HAVE ANY UNCERTAIN POSITIONS IN ITS AUDITED FINANCIAL STATEMENTS. THE ASC-740 FOOTNOTE READS AS FOLLOWS: SIGNIFICANT JUDGMENT IS REQUIRED TO EVALUATE UNCERTAIN TAX POSITIONS. THE CANCER CENTER EVALUATES ITS UNCERTAIN TAX POSITIONS ON A REGULAR BASIS. ITS EVALUATIONS ARE BASED ON A NUMBER OF FACTORS, INCLUDING CHANGES IN FACTS AND CIRCUMSTANCES, CHANGES IN TAX LAW, AND CORRESPONDENCE WITH TAX AUTHORITIES. THE CANCER CENTER ACCOUNTS FOR UNCERTAIN TAX POSITIONS BY RECOGNIZING A TAX BENEFIT OR LIABILITY AT THE LARGEST AMOUNT THAT, IN ITS JUDGMENT, IS MORE THAN 50% LIKELY TO BE REALIZED OR PAID BASED UPON TECHNICAL MERITS OF THE POSITION. THE CANCER CENTER CURRENTLY HAS NO TAX BENEFITS OR LIABILITIES RELATED TO UNCERTAIN TAX POSITIONS. EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 PROGRAM SERVICES SEMINARS 137052 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 0 0 PROGRAM SERVICES SEMINARS 12374 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES 0 0 PROGRAM SERVICES SEMINARS 18724 CENTRAL AMERICA AND THE CARIBBEAN - ANTIGUA & BARBUDA, ARUBA, BAHAMAS, 0 0 PROGRAM SERVICES SEMINARS 11799 SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL, 0 1 MAINTAINING OFFICES, EMPLOYEES OR AGENTS & PROGRAM SERVICES SEMINARS 56597 SOUTH AMERICA 0 0 PROGRAM SERVICES SEMINARS 4169 MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM SERVICES SEMINARS 7200 RUSSIA AND NEIGHBORING STATES 0 0 PROGRAM SERVICES SEMINARS 1259 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES SEMINARS 3801 0 1 0 0 0 1 249174 3801 252975 0 0 0 0 0 0 PART I, LINE 3: ACCRUAL METHOD OF ACCOUNTING WAS USED TO ACCOUNT FOR EXPENDITURES ON SCHEDULE F CONSISTENT WITH THE AUDITED FINANCIAL STATEMENTS. X 0 0 0 1 0 0 0 1 1 0 0 MICHAEL A VOGELBAUM PRG LDR NEURO ONCOLOGY 987387 0 204172 0 7524 0 46663 0 38602 0 1284348 0 0 0 JULIO M POW-SANG MD DEPT CHAIR GU 748494 0 272714 0 16332 0 199300 0 25218 0 1262058 0 0 0 G DOUGLAS LETSON FRM PRES, EVP-PIC TO 6/2024 265418 347486 314727 1025 17446 77920 39981 100802 15494 11531 653066 538764 0 0 RICARDO J GONZALEZ DEPT CHAIR SARCOMA 805264 0 215371 0 4122 0 112288 0 38421 0 1175466 0 0 0 LARY ROBINSON SR MBR THORCARDIO 898996 0 94916 0 27823 0 122454 0 14600 0 1158789 0 0 0 ERIC TOLOZA VICE CHAIR THORACIC 897731 0 129830 0 7524 0 71718 0 29458 0 1136261 0 0 0 L DAVID DE LA PARTE FRM EVP-GEN CO; ASST SEC TO 6/2024 0 462966 0 277241 0 59956 0 215205 0 29660 0 1045028 0 0 ROBERT A GATENBY DEPT CHAIR DIAGNOSTIC IMAGING 735623 0 150167 0 11388 0 129372 0 25079 0 1051629 0 0 0 JOANNA WEISS EVP CFO & ASST TREASURER 0 563868 0 236792 0 32727 0 105118 0 37521 0 976026 0 0 HUGO FERNANDEZ MD DIR, DEPT CHAIR MAL HEM MHS 708311 0 154765 0 7524 0 98527 0 25461 0 994588 0 0 0 PETER JOHSTONE DEPT CHAIR RADIATION ONCOLOGY 747356 0 90315 0 10644 0 114877 0 10663 0 973855 0 0 0 KOSJ YAMOAH DEPT CHAIR RADIATION ONCOLOGY 625837 0 201998 0 58438 0 46848 0 37573 0 970694 0 0 0 JOHN A ARRINGTON VICE CHAIR DIAGNOSTIC IMAGING 675283 0 87415 0 10644 0 133895 0 30294 0 937531 0 0 0 DONALD L KLIPPENSTEIN VICE CHAIR DIAGNOSTIC IMAGING 655313 0 69076 0 9024 0 109292 0 25191 0 867896 0 0 0 BELA KIS VICE CHAIR DIA IMAGING AS OF 12/2024 598268 0 100358 0 4122 0 70642 0 29538 0 802928 0 0 0 DAVID N THRUSH FRM DEPT CHAIR ANESTH TO 6/2023 569245 0 13958 0 10644 0 91903 0 17372 0 703122 0 0 0 SEPHALIE PATEL DEPT CHAIR ANESTHESIOLOGY 518027 0 119835 0 1140 0 47505 0 14323 0 700830 0 0 0 NIKHIL KHUSHALANI DIR, ACD CLIN RES PART 507959 0 73953 0 4114 0 53992 0 38735 0 678753 0 0 0 SUSAN VADAPARAMPIL DIRECTOR NV 0 412378 0 123199 0 20717 0 89166 0 18535 0 663995 0 0 CHARLES FLETCHER EVP-GEN COUN & ASST SEC AS OF 7/2024 0 410987 0 122232 0 11123 0 85655 0 35265 0 665262 0 0 KAREN LU PRES, EVP-PIC 0 496051 0 18000 0 103762 0 451 0 17814 0 636078 0 0 KAREN WARTENBERG VP MOFFITT MEDICAL GROUP 0 371330 0 105986 0 20067 0 116891 0 5086 0 619360 0 0 JONATHAN COHEN VICE CHAIR ANESTHESIOLOGY 464200 0 69991 0 1560 0 57820 0 35479 0 629050 0 0 0 EVAN ZASLOW VP PAYER STRATEGIES 0 329179 0 119922 0 757 0 70104 0 38720 0 558682 0 0 NASRIN ALDAWOODI VICE CHAIR ANESTHESIOLOGY TO 11/2024 419801 0 56629 0 986 0 28750 0 35533 0 541699 0 0 0 MELISSA SMITH VP FINANCE AS OF 8/2024 107918 105867 0 29093 503 314 13853 26018 8572 5661 130846 166953 0 0 YVETTE M LYONS TREMONTI FRM EVP-CFAO & ASST TREAS TO 5/2024 0 324093 0 0 0 206022 0 51122 0 16389 0 597626 0 0 HENRY REYES FRM VP-PARTNER DEV TO 4/2024 0 102671 0 0 0 2996 0 18495 0 8678 0 132840 0 0 PART I, LINE 3 LCS RELIES ON H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, A RELATED ORGANIZATION WHICH USES AN INDEPENDENT COMPENSATION CONSULTANT, COMPENSATION SURVEYS OR STUDIES, AN EXECUTIVE COMPENSATION COMMITTEE, AND THE APPROVAL BY THE BOARD OR THE EXECUTIVE COMPENSATION COMMITTEE OF THE BOARD, TO ESTABLISH THE PHYSICIAN IN CHIEF/PRESIDENT'S AND TOP MANAGEMENT OFFICIALS' COMPENSATION. PART I, LINE 4B TO BE ELIGIBLE TO PARTICIPATE IN THE 457(F) NON-QUALIFIED SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN (SERP), PARTICIPANTS MUST ELECT TO CONTRIBUTE AT LEAST 10% ACROSS THE 403(B) AND 457(B) PLANS, AND ARE VESTED AFTER 10 YEARS OF SERVICE. LUMP SUM DISTRIBUTIONS FROM THE ACCOUNT ARE MADE UPON NORMAL RETIREMENT OR TERMINATION. BELOW ARE INDIVIDUALS LISTED ON LCS'S 2024 FORM 990 PART VII, SECTION A, THAT PARTICIPATED IN THE 457(F) SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN AND THEIR RESPECTIVE AMOUNTS OF COMPENSATION CONSTRUCTIVELY RECEIVED IN TAX YEAR 2024 FROM THE PLAN: JOHN A. ARRINGTON - $1,500 L. DAVID DE LA PARTE - $50,346 CHARLES FLETCHER - $0 ROBERT A. GATENBY - $1,500 RICARDO J. GONZALEZ - $1,500 PETER JOHSTONE - $1,500 NIKHIL KHUSHALANI - $1,500 BELA KIS - $1,500 DONALD L. KLIPPENSTEIN - $1,500 G. DOUGLAS LETSON - $68,450 YVETTE M. LYONS TREMONTI - $202,839 JULIO M. POW-SANG, - $1,500 HENRY REYES - $0 LARY ROBINSON - $1,500 MELISSA SMITH - $0 DAVID N. THRUSH - $1,500 SUSAN VADAPARAMPIL - $16,764 MICHAEL A. VOGELBAUM - $0 KAREN WARTENBERG - $17,886 JOANNA WEISS - $30,428 KOSJ YAMOAH - $5,250 EVAN ZASLOW - $0 PART I, LINE 6 IN GENERAL, INCENTIVE COMPENSATION IS BASED ON MOFFITT'S ACHIEVEMENT AGAINST SPECIFIC ORGANIZATIONAL GOALS RELATED TO NET OPERATING INCOME AND ON DIVISION OR INDIVIDUAL GOALS. NET OPERATING INCOME MUST MEET OR EXCEED A CERTAIN THRESHOLD IN ORDER TO TRIGGER A PAYOUT FOR THE ORGANIZATIONAL GOAL COMPONENTS. FORM 990, PART VI, SECTION A, LINE 2 THE FOLLOWING DIRECTORS AND OFFICERS, THAT JOINTLY SERVE ON LCS AND A FOR-PROFIT RELATED ENTITY, QUALIFY AS HAVING A BUSINESS RELATIONSHIP. LCS & MOFFITT TECHNOLOGIES CORPORATION: JOANNA WEISS, LCS OFFICER AND MTC BOARD MEMBER AND OFFICER CHARLES FLETCHER, LCS OFFICER AND MTC BOARD MEMBER AND OFFICER FORM 990, PART VI, SECTION A, LINE 6 THE INSTITUTE IS THE SOLE MEMBER OF LCS. FORM 990, PART VI, SECTION A, LINE 7A AS THE SOLE MEMBER OF LCS, THE INSTITUTE SHALL HAVE THE POWER TO APPROVE, DISAPPROVE OR REMOVE ANY MEMBER OF THE BOARD OF DIRECTORS OR OFFICER OF LCS. FORM 990, PART VI, SECTION A, LINE 7B THE INSTITUTE (AS SOLE MEMBER) SHALL ALSO HAVE THE FOLLOWING POWERS: A. APPROVE, DISAPPROVE OR RECOMMEND THE ADOPTION, CHANGE, AMENDMENT OR REPEAL OF THE ARTICLES OF INCORPORATION OF THE CORPORATION; B. APPROVE, DISAPPROVE OR RECOMMEND THE ADOPTION, CHANGE, AMENDMENT OR REPEAL OF THE BYLAWS OF THE CORPORATION; C. APPROVE, DISAPPROVE OR RECOMMEND THE SELECTION OF A QUALIFIED AUDIT FIRM AND THE ANNUAL OPERATING AND CAPITAL BUDGETS OF THE CORPORATION; D. EITHER APPROVE OR DISAPPROVE THE TRANSFER, SALE, LEASE OR DISPOSITION OF ANY ASSET OF THE CORPORATION IN EXCESS OF TWO HUNDRED THOUSAND DOLLARS ($200,000.00); E. APPROVE OR DISAPPROVE THE CONFERRING OF ANY LIEN OR SECURITY INTEREST IN ASSETS OF THE CORPORATION IN EXCESS OF ONE MILLION DOLLARS ($1,000,000.00), WHETHER SAME SHALL BE IN CONNECTION WITH EITHER PUBLIC OR PRIVATE FINANCING, OR OTHERWISE; F. APPROVE OR DISAPPROVE ALL DONATIONS OR CHARITABLE CONTRIBUTIONS BY THE CORPORATION IN EXCESS OF TWENTY THOUSAND DOLLARS ($20,000.00) PER CONTRIBUTION OR ANNUAL CONTRIBUTION EXCEEDING FIFTY THOUSAND DOLLARS ($50,000.00) IN THE AGGREGATE; G. APPROVE, DISAPPROVE OR RECOMMEND THE ADOPTION OF THE CORPORATION'S MISSION AND PHILOSOPHY STATEMENT; H. APPROVE OR DISAPPROVE CAPITAL EXPENDITURES BY THE CORPORATION IN EXCESS OF ONE MILLION DOLLARS ($1,000,000.00) PER EXPENDITURE OR ONE MILLION DOLLARS ($1,000,000.00) IN THE AGGREGATE ANNUALLY; AND I. APPROVE, DISAPPROVE OR REMOVE ANY MEMBER OF THE BOARD OF DIRECTORS OR OFFICER OF THE CORPORATION. FORM 990, PART VI, SECTION A, LINE 8B LCS DOES NOT HAVE A COMMITTEE WITH AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY. FORM 990, PART VI, SECTION B, LINE 11B PRIOR TO ELECTRONICALLY FILING FORM 990 (RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX), A COPY OF THE RETURN IS PROVIDED TO THE JOINT FINANCE COMMITTEE, CONSISTING OF BOARD MEMBERS ACROSS THE CANCER CENTER, GIVING EACH MEMBER TIME TO REVIEW THE RETURN. BOARD MEMBERS HAVE THE OPPORTUNITY TO ASK QUESTIONS RELATED TO THE INFORMATION PROVIDED ON THE RETURN. LCS' FORM 990 IS ALSO PROVIDED TO THE CHIEF FINANCIAL OFFICER FOR REVIEW. BASED ON THE REVIEW ANY SUGGESTED COMMENTS OR CHANGES ARE DISCUSSED, AND IF DEEMED NECESSARY CHANGES ARE MADE PRIOR TO SIGNING. FORM 990, PART VI, SECTION B, LINE 12C H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC., THE INSTITUTE AND PARENT ORGANIZATION OF THE CANCER CENTER, DEVELOPS, IMPLEMENTS, AND ENFORCES COMPANY POLICY FOR THE CANCER CENTER AS A WHOLE. ON AN ANNUAL BASIS A PRESENTATION IS MADE TO ALL BOARD MEMBERS THROUGHOUT MOFFITT'S ENTITIES, INCLUDING LCS' BOARD MEMBERS, TO REVIEW THE CONFLICT OF INTEREST POLICY AND PROCEDURES FOR DISCLOSING ANY POTENTIAL CONFLICTS. EACH DIRECTOR, OFFICER, COMMITTEE MEMBER, AND KEY EMPLOYEE SHALL COMPLETE A CONFLICT OF INTEREST DISCLOSURE CERTIFICATION VIA THE ELECTRONIC DISCLOSURE SYSTEM. ANY DIRECTOR, OFFICER, COMMITTEE MEMBER, OR KEY EMPLOYEE WHO REASONABLY BELIEVES THAT HE OR SHE MAY HAVE AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST MUST DISCLOSE THE EXISTENCE OF AND THE MATERIAL FACTS OF THE NATURE OF HIS/HER INTEREST ON THE FORM. THE ELECTRONIC FORM IS SUBMITTED TO THE CORPORATE COMPLIANCE OFFICE, WHICH REVIEWS THE FORMS, GATHERS ADDITIONAL RELEVANT INFORMATION WHERE NECESSARY, AND PREPARES A SUMMARY OF THE DISCLOSURES TO BE REVIEWED BY THE CONFLICT OF INTEREST WORK GROUP. IF A DIRECTOR OR COMMITTEE MEMBER DISCLOSES THAT HE/SHE HAS A POTENTIAL CONFLICT OF INTEREST AT A BOARD OR COMMITTEE MEETING, SUCH DIRECTOR OR COMMITTEE MEMBER MUST DISCLOSE THE NATURE OF THE INTEREST AND ANY RELATED INFORMATION AND RESPOND TO QUESTIONS AS MAY BE REQUIRED BY THE REMAINING MEMBERS. BASED ON THE INFORMATION DISCLOSED, THE REMAINING BOARD MEMBERS WILL DETERMINE WHETHER A CONFLICT OF INTEREST EXISTS. IF A CONFLICT EXISTS THE BOARD OR COMMITTEE SHALL DETERMINE WHETHER AN ALTERNATIVE TRANSACTION OR ARRANGEMENT THAT WOULD NOT GIVE RISE TO A CONFLICT IS EQUALLY ADVANTAGEOUS. IF AN ALTERNATIVE TRANSACTION IS NOT EQUALLY ADVANTAGEOUS THE DIRECTOR OR COMMITTEE MEMBER WHO IS THE SUBJECT OF THE CONFLICT SHALL NOT VOTE ON, NOR USE HIS HER PERSONAL INFLUENCE ON, NOR PARTICIPATE IN DISCUSSIONS OR DELIBERATIONS WITH RESPECT TO THE TRANSACTION. FORM 990, PART VI, SECTION B, LINE 15 THE INSTITUTE HAS AN ESTABLISHED SUB-COMMITTEE, THE JOINT EXECUTIVE COMPENSATION & BENEFITS COMMITTEE (JEC&BC) THAT IS MADE UP ENTIRELY OF INDEPENDENT, OUTSIDE COMMITTEE MEMBERS. THIS COMMITTEE IS CHARGED WITH THE OVERSIGHT OF THE COMPENSATION OF MOFFITT DISQUALIFIED PERSONS, WHICH INCLUDES THE CEO, OTHER OFFICERS, AND KEY EMPLOYEES. TO ACCOMPLISH ITS MISSION, THE COMMITTEE CAN, AS NEEDED, AND DOES AT ITS DISCRETION, ENGAGE INDEPENDENT OUTSIDE ADVISORS, INCLUDING, BUT NOT LIMITED TO ATTORNEYS AND THIRD-PARTY COMPENSATION CONSULTANTS. ON AN ANNUAL BASIS THE JEC&BC ENGAGES A NATIONALLY KNOWN, THIRD-PARTY CONSULTING FIRM TO PROVIDE A DETAILED STUDY OF THE CASH COMPENSATION FOR EACH DISQUALIFIED PERSON. THE CONSULTANT USES A VARIETY OF PUBLISHED SURVEYS COMPILED BY INDEPENDENT FIRMS TO PROVIDE THE INSTITUTE SOURCE DATA FOR THE STUDY. USING FUNCTIONALLY COMPARABLE POSITIONS IN OTHER SIMILARLY SIZED, NOT-FOR-PROFIT AND FOR-PROFIT HEALTHCARE, ACADEMIC AND RESEARCH ORGANIZATIONS, THE CONSULTING FIRM PRODUCES A STUDY THAT COMPARES EACH DESIGNATED MOFFITT POSITION TO ITS APPROPRIATE MARKET EQUIVALENT, INCLUDING THE VALUE OF ALL BENEFITS AND PERQUISITES (CASH AND NON-CASH) PROVIDED AS COMPENSATION TO THE DISQUALIFIED PERSONS. THE RESULTING DATA IS PROVIDED TO THE DIRECTOR OF COMPENSATION, WHO IS NOT INCLUDED IN THE DISQUALIFIED PERSON CATEGORY, FOR USE IN THE FORMULATION OF RECOMMENDATIONS FOR COMPENSATION CHANGES TO MAINTAIN MARKET COMPETITIVENESS OR TO REWARD PERFORMANCE. THESE RECOMMENDATIONS, ALONG WITH THE CONSULTANT'S COMPARABILITY DATA, ARE PRESENTED TO THE JEC&BC FOR THE COMMITTEE MEMBERS TO CONFIRM ITS REASONABLENESS, MAKE MODIFICATIONS AS IT DEEMS NECESSARY AND PROVIDE FINAL APPROVAL. MINUTES ARE KEPT AT EACH OF THESE ANNUAL MEETINGS DETAILING THE RECOMMENDATIONS PRESENTED AND THE DECISIONS MADE BY THE COMMITTEE. THESE MINUTES ARE PUBLISHED TO THE COMMITTEE AT THE NEXT MEETING AND REPORTED BACK TO THE INSTITUTE BOARD. FORM 990, PART VI, SECTION C, LINE 19 LCS MAKES AVAILABLE ITS CONSOLIDATED AUDITED FINANCIAL STATEMENTS TO THE PUBLIC THROUGH DACBOND, A THIRD PARTY VENDORS' WEBSITES. IN ADDITION, FORM 990 IS MADE AVAILABLE ON GUIDESTAR AS WELL AS MOFFITT'S WEBSITE. ALL ORGANIZING AND GOVERNING DOCUMENTS SUCH AS FORM 1023, CONFLICTS OF INTEREST POLICY, AND BYLAWS AS WELL AS FORM 990 AND AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE UPON REQUEST. FORM 990, PART VII, SECTION A, LINE 1A: EMPLOYEES WHO ARE LISTED ON MOFFITT LCS'S FORM 990 ARE EMPLOYEES WHOSE W-2'S WERE ISSUED BY THE INSTITUTE, THE COMMON PAYMASTER AND RELATED ENTITY. PROCEDURES TO REPORT COMPENSATION OF EMPLOYEES ON FORM 990 PART VII AND ON SCHEDULE J ARE IN ACCORDANCE WITH IRS INSTRUCTIONS FOR EACH RESPECTIVE SECTION. FORM 990, PART IX, COLUMN (D): THERE ARE NO FUNDRAISING EXPENSES BECAUSE H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION, INC. HANDLES ALL FUNDRAISING ACTIVITIES FOR THE INSTITUTE AND ITS SUBSIDIARIES. FORM 990, PART IX, LINE 24A: CERTAIN MOFFITT CANCER CENTER'S INTERCOMPANY OVERHEAD HAS BEEN ALLOCATED FROM THE PARENT (THE INSTITUTE) ENTITY TO LCS AND THOSE AMOUNTS ARE INCLUDED IN COLUMN (C) AND THEN REALLOCATED ON LINE 24A TO THE PROPER FUNCTIONAL EXPENSE CATEGORIES. FORM 990, PART XI, LINE 9: OTHER CHANGES IN NET ASSETS RELATE TO THE CLOSE OUT OF INTERCOMPANY ACCOUNTS RECEIVABLE IN THE AMOUNT OF $211,845,881 AND ($14,872) IN GRANT REFUND RECLASS. H LEE MOFFITT CANCER CTR & RESEARCH INSTITUTE HOSPITAL INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 593238634 PATIENT CARE FL 501(C)(3) LINE 3 H LEE MOFFITT CANCER CTR & RES INST INC 0 H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 592451713 PARENT-RESEARCH FL 501(C)(3) LINE 7 N/A 0 H LEE MOFFITT CANCER CTR & RESEARCH INSTITUTE FOUNDATION INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 593238636 FUNDRAISING FL 501(C)(3) LINE 7 H LEE MOFFITT CANCER CTR & RES INST INC 0 MOFFITT REAL ESTATE HOLDING CORPORATION 12902 MAGNOLIA DRIVE TAMPA FL 33612 923387708 HOLDING TITLE FL 501(C)(2) H LEE MOFFITT CANCER CTR & RES INST INC 0 MOFFITT LIFESCIENCES CAMPUS MANAGEMENT CORPORATION 12902 MAGNOLIA DRIVE TAMPA FL 33612 923388291 REAL ESTATE PROPERTY MANAGEMENT FL 501(C)(3) LINE 12A, I H LEE MOFFITT CANCER CTR & RES INST INC 0 MOFFITT TECHNOLOGIES CORPORATION 12902 MAGNOLIA DRIVE TAMPA FL 33612 300332914 TECHNOLOGY MANAGEMENT FL N/A C 0 PAGONA HEALTH LLC (AS OF 111524) 12902 MAGNOLIA DRIVE TAMPA FL 33612 994698652 MEDICAL SERVICES FL N/A C 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 1